Lactic acidosis caused by nucleoside analogues

Joseph R. Shiber

doi:10.1016/j.ajem.2004.10.002

Switch to Standard View Switch to Enhanced View

Lactic acidosis caused by nucleoside analogues

Presented as a poster at the 2001 Research Day for the American College of Physicians, Maryland Chapter.

Joseph R. Shiber, MD

Department of Emergency Medicine, East Carolina University, Greenville, NC 27834, USA

Department of Internal Medicine, East Carolina University, Greenville, NC 27834, USA

DOI: http://dx.doi.org/10.1016/j.ajem.2004.10.002

Purchase this article (PDF Included)

$31.50 USD (24 hour access)

Subscribe to this title

To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect.

Type B lactic acidosis, lactate accumulation without any clinical evidence of tissue hypoxia, occurs because of impairment in lactate use. Type B is further divided into subcategories based on underlying etiology. Type B1 is associated with systemic disease such as renal and hepatic failure, diabetes, and malignancy. Type B3 is associated with inherited metabolic disorders. Type B2 is known to be caused by several classes of drugs including biguanides, alcohols, iron, isoniazid, and salicylates.

To access this article, please choose from the options below

Log In

Register

Create a new account

Purchase access to this article

$31.50 USD|Online access for 24 hours

Claim Access

If you are a current subscriber with Society Membership or an Account Number, claim your access now.

Subscribe to this title

Purchase a subscription to gain access to this and all other articles in this journal.

Institutional Access

Visit ScienceDirect to see if you have access via your institution.

Lactic acidosis caused by nucleoside analogues

To access this article, please choose from the options below

Log In

Register

Purchase access to this article

Claim Access

Subscribe to this title

Institutional Access

Article Tools

Related Articles